Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Follow-Up Questions
Qui est le CEO de Uni-Bio Science Group Ltd ?
Mr. Zhi Gang Zhao est le Chief Executive Officer de Uni-Bio Science Group Ltd, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action UNBSF ?
Le prix actuel de UNBSF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Uni-Bio Science Group Ltd ?
Uni-Bio Science Group Ltd appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Uni-Bio Science Group Ltd ?
La capitalisation boursière actuelle de Uni-Bio Science Group Ltd est de $0
